100+ Free Arab Board Family Medicine Clinical Practice Questions

Prepare for the Arab Board Family Medicine Final Clinical and Oral Examination (ABHS) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Arab Board Specialty Certification Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Sample Arab Board Family Medicine Clinical Practice Questions

Try these sample questions to test your Arab Board Family Medicine Clinical exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 56-year-old man with a 6-year history of type 2 diabetes presents for a routine chronic disease review. His clinic blood pressure is 144/92 mmHg (confirmed on repeat measurement), and his urinary albumin-to-creatinine ratio (uACR) is 18 mg/mmol (elevated, indicating microalbuminuria). His serum creatinine is 88 µmol/L with an estimated GFR of 78 mL/min/1.73 m². Which antihypertensive agent is the most appropriate first-line choice for this patient?

A.Amlodipine

B.Ramipril

C.Hydrochlorothiazide

D.Atenolol

Explanation: In patients with diabetes, hypertension, and albuminuria (uACR ≥ 3 mg/mmol), an ACE inhibitor such as ramipril or an ARB is the first-line antihypertensive of choice. These agents preferentially dilate the efferent renal arteriole, reducing intraglomerular hydrostatic pressure and slowing the progression of diabetic nephropathy beyond systemic blood pressure reduction alone. Calcium channel blockers and thiazide diuretics can be added if blood pressure targets are not met.

2A 62-year-old woman with type 2 diabetes and a history of myocardial infarction 2 years ago attends clinic with an HbA1c of 8.4% despite adherence to metformin 1000 mg twice daily. Her BMI is 32 kg/m² and eGFR is 75 mL/min/1.73 m². Which second-line glucose-lowering agent is most appropriate to add to improve her glycemic control and reduce cardiovascular mortality?

A.Gliclazide

B.Empagliflozin

C.Pioglitazone

D.Sitagliptin

Explanation: In patients with established atherosclerotic cardiovascular disease (ASCVD), guidelines from the ADA and EASD recommend adding an SGLT2 inhibitor (such as empagliflozin) or a GLP-1 receptor agonist with proven cardiovascular benefit, irrespective of baseline HbA1c. SGLT2 inhibitors lower blood glucose, induce weight loss, reduce blood pressure, and significantly decrease major adverse cardiovascular events and heart failure hospitalizations. Metformin and SGLT2 inhibitors represent the standard of care for secondary cardiovascular prevention in diabetic patients.

3A 68-year-old man with type 2 diabetes and stage 3b chronic kidney disease (eGFR 38 mL/min/1.73 m², uACR 45 mg/mmol) is currently taking metformin 500 mg daily and lisinopril 20 mg daily. His HbA1c is 7.9%. Which medication should be initiated to provide optimal kidney and cardiovascular disease protection?

A.Dapagliflozin

B.Glimepiride

C.Saxagliptin

D.Acarbose

Explanation: Dapagliflozin and other SGLT2 inhibitors are strongly recommended for patients with chronic kidney disease (eGFR 20–60 mL/min/1.73 m² or significant albuminuria) with or without diabetes. SGLT2 inhibitors reduce intraglomerular pressure, reduce albuminuria, and significantly slow the progression of CKD, end-stage kidney disease, and cardiovascular death. In patients with eGFR < 45 mL/min, the glucose-lowering efficacy of SGLT2 inhibitors is attenuated, but their renoprotective and cardioprotective benefits remain robust.

4A 52-year-old woman with longstanding poorly controlled type 2 diabetes presents with recurrent postprandial fullness, early satiety, nausea, and vomiting of undigested food several hours after eating. A gastric emptying scintigraphy confirms delayed gastric emptying consistent with diabetic gastroparesis. In addition to optimizing glycemic control and recommending small, low-fiber, low-fat meals, which pharmacological agent is most appropriate for initial symptom management?

A.Liraglutide

B.Metoclopramide

C.Loperamide

D.Hyoscine butylbromide

Explanation: Metoclopramide is a prokinetic agent (dopamine D2 receptor antagonist with 5-HT4 agonist properties) approved for the short-term symptomatic treatment of diabetic gastroparesis. It enhances gastric motility and accelerates gastric emptying while providing central antiemetic action. Treatment duration should generally be limited (or closely monitored) due to the risk of extrapyramidal side effects and tardive dyskinesia.

5A 48-year-old man with type 1 diabetes on insulin glargine at bedtime and insulin aspart before meals reports waking up with high fasting blood glucose levels (14–16 mmol/L). He complains of vivid nightmares, night sweats, and morning headaches. Checking his blood glucose at 03:00 AM reveals a level of 2.6 mmol/L. What is the most appropriate management strategy for his morning hyperglycemia?

A.Increase the bedtime insulin glargine dose

B.Reduce the bedtime insulin glargine dose

C.Add a rapid-acting insulin dose at 03:00 AM

D.Switch insulin glargine to regular human insulin at bedtime

Explanation: This clinical picture represents the Somogyi effect (rebound hyperglycemia), where nocturnal hypoglycemia triggers a counter-regulatory surge of glucagon, epinephrine, cortisol, and growth hormone, leading to elevated morning fasting glucose levels. The 03:00 AM hypoglycemia (2.6 mmol/L) confirms nocturnal over-basalization rather than the dawn phenomenon (which shows normal or elevated 03:00 AM glucose). The definitive management is to reduce the evening or bedtime basal insulin dose (or provide a bedtime protein-carbohydrate snack).

6A 45-year-old male non-smoker with no chronic medical conditions is found to have clinic blood pressure readings of 146/94 mmHg and 148/92 mmHg across two separate visits. Ambulatory blood pressure monitoring confirms a daytime average of 142/90 mmHg. Physical examination and baseline investigations (serum creatinine, electrolytes, fasting lipids, glucose, and ECG) are normal. What is the most appropriate initial pharmacological treatment along with lifestyle modifications?

A.Amlodipine or Enalapril monotherapy

B.Triple combination therapy with Lisinopril, Amlodipine, and Indapamide

C.Clonidine monotherapy

D.Immediate hospital admission for intravenous Nitroprusside

Explanation: For patients under 55 years of age (non-black origin) with stage 1 essential hypertension confirmed on ambulatory monitoring, first-line pharmacological treatment is monotherapy with an ACE inhibitor (or ARB) or a calcium channel blocker (such as amlodipine). If blood pressure is not controlled on monotherapy, step-2 dual combination therapy (ACEi/ARB plus CCB) is initiated. Lifestyle modifications (DASH diet, salt reduction, regular exercise) should accompany pharmacological treatment.

7A 60-year-old man has persistent clinic blood pressure of 152/96 mmHg despite confirmed adherence to maximal doses of lisinopril (40 mg daily), amlodipine (10 mg daily), and indapamide (2.5 mg daily). His serum potassium is 4.2 mmol/L, sodium is 139 mmol/L, and eGFR is 65 mL/min/1.73 m². What is the most appropriate next step in pharmacological management for this patient with resistant hypertension?

A.Add low-dose Spironolactone (25 mg daily)

B.Add Atenolol 100 mg daily

C.Switch Lisinopril to Losartan

D.Discontinue Indapamide and add Furosemide

Explanation: Resistant hypertension is defined as blood pressure that remains above target despite adherence to optimal doses of three antihypertensive agents from different classes, one of which is a diuretic. The PATHWAY-2 trial and clinical guidelines establish low-dose spironolactone (25–50 mg daily) as the most effective fourth-line add-on agent, provided serum potassium is < 4.5 mmol/L and eGFR is > 45 mL/min/1.73 m². Renal function and electrolytes should be rechecked 1–2 weeks after initiation.

8A 38-year-old woman presents with difficult-to-control hypertension (BP 164/102 mmHg) on two medications. Routine blood tests reveal a serum potassium of 3.0 mmol/L (unprovoked hypokalemia) and serum bicarbonate of 30 mmol/L. She takes no diuretics or licorice. Which diagnostic test is the most appropriate initial screening step for her suspected secondary hypertension?

A.Plasma Aldosterone-to-Renin Ratio (ARR)

B.24-hour urinary free cortisol

C.Renal artery magnetic resonance angiography

D.Plasma free metanephrines

Explanation: The clinical presentation of young-onset or resistant hypertension with unprovoked hypokalemia and metabolic alkalosis is highly suspicious for primary aldosteronism (Conn syndrome). The recommended initial screening test is the morning paired plasma aldosterone concentration and plasma renin activity (or direct renin concentration) to calculate the Aldosterone-to-Renin Ratio (ARR). An elevated aldosterone with suppressed renin yielding a high ARR is positive and warrants confirmatory dynamic testing (such as oral salt loading or saline infusion).

9A 24-year-old university student with mild persistent asthma uses a short-acting beta-2 agonist (salbutamol) inhaler 4 to 5 days per week and wakes up with wheezing once weekly. She has no regular preventer inhaler. Her spirometry shows an FEV1 of 82% predicted. According to GINA guidelines, what is the most appropriate step in maintenance therapy?

A.Initiate as-needed low-dose ICS-formoterol combination therapy (or regular daily low-dose ICS plus as-needed SABA)

B.Prescribe oral Montelukast monotherapy and discontinue all inhalers

C.Initiate high-dose ICS plus LABA plus oral Prednisolone daily

D.Continue Salbutamol alone and instruct her to double the puffs before exercise

Explanation: According to GINA (Global Initiative for Asthma) guidelines, SABA monotherapy is no longer recommended because it increases the risk of severe exacerbations and asthma-related mortality. For patients with symptoms more than twice weekly (Step 2), the preferred controller track is as-needed low-dose ICS-formoterol (MART/AIR approach) or regular daily low-dose inhaled corticosteroid (ICS) maintenance with SABA reliever. This addresses the underlying airway inflammation from the earliest disease stages.

10A 30-year-old woman with known asthma arrives at the primary care urgent clinic with acute breathlessness and wheezing. She can speak in short phrases only, has a respiratory rate of 28 breaths/min, heart rate 112 bpm, oxygen saturation 93% on room air, and peak expiratory flow (PEF) of 55% of her personal best. What is the most appropriate immediate medical management?

A.Administer nebulized Salbutamol plus Ipratropium bromide, oral Prednisolone 40 mg, and supplemental oxygen to maintain saturation 93–95%

B.Administer subcutaneous Epinephrine and intravenous Aminophylline infusion

C.Prescribe inhaled Fluticasone propionate 500 mcg and send her home immediately

D.Give an intramuscular injection of Cefotaxime and oral codeine linctus

Explanation: This patient has a moderate-to-severe acute asthma exacerbation (PEF 50–75%, tachycardia, tachypnea, speech in phrases). Immediate management in primary care includes repetitive or continuous inhaled short-acting beta-2 agonist (salbutamol) combined with an inhaled anticholinergic (ipratropium bromide), early administration of systemic corticosteroids (oral prednisolone 40–50 mg or IV hydrocortisone), and controlled oxygen therapy aiming for SpO2 of 93–95%. The patient should be monitored closely and transferred to an emergency department if there is poor response.

About the Arab Board Family Medicine Clinical Exam

The Arab Board Family Medicine Final Clinical and Oral Examination is the high-stakes clinical exit assessment for senior family medicine residents. Administered by the ABHS Scientific Council of Family Medicine across Arab League member states, it evaluates bedside clinical judgment, multi-problem management in primary care, chronic disease protocols, maternal-child health, urgent care triage, geriatric assessments, and medical ethics/communication. This study bank adapts core clinical station scenarios into 100 comprehensive English-language practice questions.

Assessment

Multi-station Objective Structured Clinical Examination (OSCE) and structured clinical problem-solving stations evaluating communication, patient history, physical examination, diagnostic reasoning, and management plans.

Time Limit

Approximately 2 to 3 hours

Passing Score

The overall passing threshold is typically set around 60% as determined by criterion-referenced standard-setting procedures of the ABHS Scientific Council of Family Medicine.

Exam Fee

Set by ABHS and national councils in member countries across the Arab League; candidates should confirm current fees with their local training program or national council. (Arab Board of Health Specializations (ABHS) - Scientific Council of Family Medicine)

Arab Board Family Medicine Clinical Exam Content Outline

25%

Chronic Disease Management

Evidence-based management of diabetes mellitus, hypertension, dyslipidemia, asthma, COPD, heart failure, and chronic kidney disease in primary care.

14%

Women's Health and Antenatal Care

Antenatal screening, gestational diabetes, pre-eclampsia, contraception, abnormal uterine bleeding, menopause, cervical screening, and postpartum care.

14%

Child and Adolescent Health

Pediatric immunization schedules, growth milestones, acute respiratory infections, dehydration, developmental screening, and pediatric red flags.

12%

Acute Undifferentiated and Urgent Care

Triage and initial management of acute chest pain, dyspnea, acute abdomen, anaphylaxis, sepsis, severe headache, and surgical emergencies.

10%

Mental Health in Primary Care

Diagnosis and management of major depressive disorder, generalized anxiety, panic disorder, insomnia, somatoform disorders, and suicide risk assessment.

10%

Preventive Medicine and Screening

Cancer screening protocols, cardiovascular risk stratification, adult vaccinations, smoking cessation, and lifestyle behavior change counselling.

Elderly Care and Geriatrics

Comprehensive geriatric assessment, polypharmacy and deprescribing, falls evaluation, dementia versus delirium, and osteoporosis management.

Patient Consultation, Communication and Bioethics

Patient-centered consultation models, breaking bad news (SPIKES), informed consent, medical confidentiality, autonomy, and managing challenging encounters.

How to Pass the Arab Board Family Medicine Clinical Exam

What You Need to Know

Passing score: The overall passing threshold is typically set around 60% as determined by criterion-referenced standard-setting procedures of the ABHS Scientific Council of Family Medicine.
Assessment: Multi-station Objective Structured Clinical Examination (OSCE) and structured clinical problem-solving stations evaluating communication, patient history, physical examination, diagnostic reasoning, and management plans.
Time limit: Approximately 2 to 3 hours
Exam fee: Set by ABHS and national councils in member countries across the Arab League; candidates should confirm current fees with their local training program or national council.

Keys to Passing

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Arab Board Family Medicine Clinical Study Tips from Top Performers

1Structure your clinical consultation using recognized frameworks (such as the Calgary-Cambridge guide) to ensure comprehensive history taking, ICE (Ideas, Concerns, Expectations), and shared decision-making.

2Master current clinical practice guidelines for primary care chronic diseases, particularly combination therapy thresholds, renal dose adjustments, and guideline-directed medical therapy in cardiovascular and metabolic conditions.

3Practice structured verbal explanations for complex counseling stations, such as breaking bad news (SPIKES protocol), vaccine hesitancy counseling, and addressing medication non-adherence with motivational interviewing techniques.

Frequently Asked Questions

What is the format of the Arab Board Family Medicine Final Clinical and Oral Exam?

The examination is conducted as an Objective Structured Clinical Examination (OSCE) comprising multiple active and rest stations, paired with structured clinical/oral problem-solving cases where examiners evaluate candidates on clinical history taking, physical examination, data interpretation, communication skills, and management planning.

What is the passing score for the Arab Board Family Medicine Clinical Exam?

The passing standard is criterion-referenced and set by the ABHS Scientific Council of Family Medicine, generally requiring an overall score of approximately 60% and passing a minimum specified number of clinical stations. Candidates must verify exact sitting standards with their national training council.

How does this practice question bank assist in clinical and oral exam preparation?

While the official ABHS examination evaluates candidates interactively through simulated patients and viva voce encounters, this 100-question clinical scenario bank translates high-yield station scenarios into structured decision-making questions, reinforcing evidence-based management, red-flag triage, and communication principles.

What core clinical topics are most heavily tested in the ABHS Family Medicine exit exam?

High-yield topics include multi-morbidity chronic disease management (diabetes, hypertension, COPD, heart failure), maternal and child health (antenatal screening, pediatric emergencies, vaccine schedules), acute primary care triage (chest pain, dyspnea, acute abdomen), mental health, geriatrics/polypharmacy, and medical bioethics.

100+ Free Arab Board Family Medicine Clinical Practice Questions

Explore More Arab Board Specialty Certification Exams

Arab Board Pediatrics Part 1 Written Exam (ABHS)

Arab Board Anatomic Pathology Part 1 Written Exam (ABHS)

Arab Board Anesthesia and Intensive Care Final Clinical and Oral Exam (ABHS)

Arab Board Anesthesia and Intensive Care Final Written Exam (ABHS)

Arab Board Anesthesia Part 1 Written Exam (ABHS)

Arab Board Clinical Pathology Part 1 Written Exam (ABHS)